EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSBSLG00000017747
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSBSLG00000016762
Gene Symbol: LOC114846501
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSBSLG00000019880
Gene Symbol: LOC114843157
3 Cross references
221 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSBSLG00000015654
Gene Symbol: LOC114845428
2 Cross references
194 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSBSLG00000009538
Gene Symbol: LOC114866612
3 Cross references
206 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSBSLG00000001931
Gene Symbol: LOC114857800
3 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSBSLG00000017733
Gene Symbol: PDPK1
3 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSBSLG00000022426
Gene Symbol: LOC114862993
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S4

Ensembl ID : ENSBSLG00000014788
Gene Symbol: LOC114851140
3 Cross references
497 Possible Orthologues:

40s Ribosomal Protein Sa

Ensembl ID : ENSBSLG00000006254
Gene Symbol: LOC114860271
3 Cross references
516 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSBSLG00000026405
Gene Symbol: NT5E
3 Cross references
194 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSBSLG00000011445
Gene Symbol: HTR1B
3 Cross references
178 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).